352 related articles for article (PubMed ID: 30060730)
1. Liver Transplant in Patients with Primary Sclerosing Cholangitis: Long-Term Experience of a Single Center.
Astarcioglu I; Egeli T; Unek T; Akarsu M; Sagol O; Obuz F; Ozbilgin M; Aysal Agalar A; Ağalar C
Exp Clin Transplant; 2018 Aug; 16(4):434-438. PubMed ID: 30060730
[TBL] [Abstract][Full Text] [Related]
2. Clinical analysis of liver transplantation in autoimmune liver diseases.
Zhong CP; Xi ZF; Xia Q
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):27-31. PubMed ID: 29428100
[TBL] [Abstract][Full Text] [Related]
3. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
4. Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.
Imai D; Yoshizumi T; Sakata K; Ikegami T; Itoh S; Harada N; Motomura T; Toshima T; Mano Y; Soejima Y; Maehara Y
Transplantation; 2018 Sep; 102(9):e382-e391. PubMed ID: 29912047
[TBL] [Abstract][Full Text] [Related]
5. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
[TBL] [Abstract][Full Text] [Related]
7. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.
Venkat VL; Ranganathan S; Mazariegos GV; Sun Q; Sindhi R
Liver Transpl; 2014 Jun; 20(6):679-86. PubMed ID: 24634351
[TBL] [Abstract][Full Text] [Related]
9. Survival without biliary complications after liver transplant for primary sclerosing cholangitis.
Mogl MT; Albert K; Pascher A; Sauer I; Puhl G; Gül S; Schönemann C; Neuhaus P; Guckelberger O
Exp Clin Transplant; 2013 Dec; 11(6):510-21. PubMed ID: 24344944
[TBL] [Abstract][Full Text] [Related]
10. Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis.
Martin EF; Levy C
Semin Liver Dis; 2017 Nov; 37(4):305-313. PubMed ID: 29272893
[TBL] [Abstract][Full Text] [Related]
11. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases.
Sheng R; Zajko AB; Campbell WL; Abu-Elmagd K
AJR Am J Roentgenol; 1993 Aug; 161(2):297-300. PubMed ID: 8333366
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
13. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience.
Emek E; Serin A; Sahin T; Yazici P; Yuzer Y; Tokat Y; Bozkurt B
Transplant Proc; 2019 Sep; 51(7):2439-2441. PubMed ID: 31405746
[TBL] [Abstract][Full Text] [Related]
14. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.
Kugelmas M; Spiegelman P; Osgood MJ; Young DA; Trotter JF; Steinberg T; Wachs ME; Bak T; Kam I; Everson GT
Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.
Duclos-Vallee JC; Sebagh M
Liver Transpl; 2009 Nov; 15 Suppl 2():S25-34. PubMed ID: 19876939
[TBL] [Abstract][Full Text] [Related]
16. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.
Hildebrand T; Pannicke N; Dechene A; Gotthardt DN; Kirchner G; Reiter FP; Sterneck M; Herzer K; Lenzen H; Rupp C; Barg-Hock H; de Leuw P; Teufel A; Zimmer V; Lammert F; Sarrazin C; Spengler U; Rust C; Manns MP; Strassburg CP; Schramm C; Weismüller TJ;
Liver Transpl; 2016 Jan; 22(1):42-52. PubMed ID: 26438008
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
Linder S; Söderlund C
Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome.
Strasser S; Sheil AG; Gallagher ND; Waugh R; McCaughan GW
J Gastroenterol Hepatol; 1993; 8(3):238-43. PubMed ID: 8518394
[TBL] [Abstract][Full Text] [Related]
19. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.
Henson JB; Patel YA; Wilder JM; Zheng J; Chow SC; King LY; Muir AJ
Dig Dis Sci; 2017 Nov; 62(11):3200-3209. PubMed ID: 28391417
[TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience.
Morris-Stiff G; Bhati C; Olliff S; Hübscher S; Gunson B; Mayer D; Mirza D; Buckels J; Bramhall SR
Dig Surg; 2008; 25(2):126-32. PubMed ID: 18446034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
